PharmaBoardroom

NEW Korea Pharma Report Out Now

One of the indisputable economic success stories of the last half-century, South Korea now stands as the world’s 11th largest economy, with a…

Chengbin Wu – CEO, EpimAb Biotherapeutics, China

Dr Chengbin Wu, founder and CEO of EpimAb Biotherapeutics, introduces their exciting and proprietary bispecific antibody-generating platform,…

Frédéric Cren – Chairman, CEO & Co-Founder,…

Inventiva is a French clinical-stage biotech company focused on developing oral small molecule epigenetic modulators in therapeutic areas with high…

Jean-Jacques Garaud – CEO, Inotrem, France

Inotrem is a French biotech company developing a novel approach to target inflammatory diseases based on the TREM-1 pathway. Its CEO, Dr Jean-Jacques…

Philippe Archinard – CEO, Transgene, France

Phillipe Archinard CEO of Transgene shares insights on the latest technologies being developed by the gene therapy specialist, explains how France’s…

William (Wei) Cao – Founder, Chairman & CEO, Gracell,…

William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big…

Jin Woo Lee – Founder & CEO, YD Global Life Science,…

YD Global Life Science is a Korean biopharmaceutical company with ambitions to become a global leader in new drug development with USD 1 billion in…

Christine Placet – CEO, Horama, France

Christine Placet, CEO of French biotech Horama, discusses the objective of becoming one of the key players in the field of ophthalmic gene therapy.…

André Choulika – Chairman & CEO, Cellectis, France

André Choulika, Chairman and CEO of Cellectis, discusses how UCART will revolutionize cell therapy as a universal gene-edited solution as opposed to…

Jun Bao – President & CEO, Impact Therapeutics, China

Dr Jun Bao, appointed president and CEO of Impact Therapeutics in October 2018, shares his aspirations for Impact to be a leader in synthetic…

John Yu – CEO, CGeneTech, China

Dr John Yu, co-founder and CEO of CGeneTech, shares the exciting story behind the company’s establishment in 2010; its balanced philosophy on new…

David Kim – CEO, Cure Therapeutics & CureCell, South…

Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative…

Tagged with biotech